Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
Saved in:
Bibliographic Details
Main Authors: Nitz, U. (Author), Gluz, O. (Author), Huober, J. (Author), Kreipe, H. H. (Author), Kates, R. E. (Author), Hartmann, A. (Author), Erber, R. (Author), Scholz, M. (Author), Lisboa, B. (Author), Mohrmann, S. (Author), Möbus, V. (Author), Augustin, D. (Author), Hoffmann, G. (Author), Weiss, E. (Author), Böhmer, S. (Author), Kreienberg, R. (Author), Du Bois, A. (Author), Sattler, D. (Author), Thomssen, C. (Author), Kiechle, M. (Author), Jänicke, F. (Author), Wallwiener, D. (Author), Harbeck, N. (Author), Kuhn, W. (Author)
Format: Electronic eBook
Language:English
Published: Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) 2016
Subjects:
Online Access:Volltext
Volltext
Volltext
Item Description:Aus: Annals of Oncology 25.8 (2014): S. 1551-1557. <http://annonc.oxfordjournals.org/content/25/8/1551.abstract>
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.
This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively.
Physical Description:1 Online-Ressource
Format:Langzeitarchivierung gewährleistet, LZA

There is no print copy available.

Interlibrary loan Place Request Caution: Not in THWS collection! Get full text